Senior Immuno-Oncology Scientist & Team Lead

Boehringer Ingelheim GmbH; Ridgefield (CT); Vor Ort; USD 167.000 - 250.000; Vollzeit

Zusammenfassung

Boehringer Ingelheim is seeking a Senior Principal Scientist for the Immuno-Oncology focused Oncology Research Department in Ridgefield, CT. You will lead multidisciplinary discovery teams, design experiments, and guide project strategy to deliver differentiated candidates.

The role emphasizes scientific leadership, collaboration, and communication with senior management. You will develop staff, manage budgets, and drive biomarker discovery and translational programs while staying current with

Qualifikationen

• Ph.D. or equivalent in a relevant discipline with 7+ years of experience.
• Industry immuno-oncology experience preferred (5+ years).
• Strong leadership and personnel development experience.
• Experience moving projects from discovery to late-stage development.
• Excellent written and oral communication, ability to present to executives.

Aufgaben

• Leads multidisciplinary discovery teams and shapes strategy for differentiation.
• Directs experimental design and oversight of junior staff; manages pipeline milestones.
• Proposes therapeutic concepts and leads target identification, validation and biomarker work.
• Communicates results through technical reports and presentations to senior management.
• Manages staff development and budgets within area of responsibility.

Kenntnisse

People leadership

Analytical thinking

Scientific communication

Experiment design

Ausbildung

Ph.D./D.V.M./V.M.D.

Tools

Flow cytometry

Cell-based assays

Jobbeschreibung

Boehringer Ingelheim is seeking a Senior Principal Scientist for the Immuno-Oncology focused Oncology Research Department in Ridgefield, CT. You will lead multidisciplinary discovery teams, design experiments, and guide project strategy to deliver differentiated candidates.

The role emphasizes scientific leadership, collaboration, and communication with senior management. You will develop staff, manage budgets, and drive biomarker discovery and translational programs while staying current with